Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4463 | 1707 | 48.2 | 79% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUROMELANIN | Author keyword | 50 | 45% | 5% | 84 |
2 | AMINOCHROME | Author keyword | 22 | 66% | 1% | 21 |
3 | 5 S CYSTEINYLDOPAMINE | Author keyword | 20 | 100% | 1% | 9 |
4 | DOPAMINE QUINONE | Author keyword | 15 | 59% | 1% | 17 |
5 | BRUCE R P ORT FAMILY | Address | 13 | 80% | 0% | 8 |
6 | SHANDONG PROV PATHOGENESIS PREVENT NEUR | Address | 10 | 40% | 1% | 19 |
7 | CYSTEINYLDOPAMINE | Author keyword | 9 | 83% | 0% | 5 |
8 | 5 S CYSTEINYL DOPAMINE | Author keyword | 8 | 75% | 0% | 6 |
9 | CATECHOLAMINE REGULATED PROTEIN | Author keyword | 8 | 75% | 0% | 6 |
10 | DOPAMINOCHROME | Author keyword | 8 | 100% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEUROMELANIN | 50 | 45% | 5% | 84 | Search NEUROMELANIN | Search NEUROMELANIN |
2 | AMINOCHROME | 22 | 66% | 1% | 21 | Search AMINOCHROME | Search AMINOCHROME |
3 | 5 S CYSTEINYLDOPAMINE | 20 | 100% | 1% | 9 | Search 5+S+CYSTEINYLDOPAMINE | Search 5+S+CYSTEINYLDOPAMINE |
4 | DOPAMINE QUINONE | 15 | 59% | 1% | 17 | Search DOPAMINE+QUINONE | Search DOPAMINE+QUINONE |
5 | CYSTEINYLDOPAMINE | 9 | 83% | 0% | 5 | Search CYSTEINYLDOPAMINE | Search CYSTEINYLDOPAMINE |
6 | 5 S CYSTEINYL DOPAMINE | 8 | 75% | 0% | 6 | Search 5+S+CYSTEINYL+DOPAMINE | Search 5+S+CYSTEINYL+DOPAMINE |
7 | CATECHOLAMINE REGULATED PROTEIN | 8 | 75% | 0% | 6 | Search CATECHOLAMINE+REGULATED+PROTEIN | Search CATECHOLAMINE+REGULATED+PROTEIN |
8 | DOPAMINOCHROME | 8 | 100% | 0% | 5 | Search DOPAMINOCHROME | Search DOPAMINOCHROME |
9 | IRON ADMINISTRATION | 7 | 64% | 0% | 7 | Search IRON+ADMINISTRATION | Search IRON+ADMINISTRATION |
10 | DHBT 1 | 6 | 80% | 0% | 4 | Search DHBT+1 | Search DHBT+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN SUBSTANTIA NIGRA | 45 | 38% | 6% | 95 |
2 | NEUROMELANIN | 41 | 37% | 5% | 90 |
3 | MPTP INDUCED HEMIPARKINSONIAN MONKEYS | 29 | 88% | 1% | 14 |
4 | GUINEA PIG STRIATUM | 26 | 87% | 1% | 13 |
5 | MESENCEPHALIC CELL CULTURES | 26 | 64% | 1% | 25 |
6 | PURIFIED HUMAN NEUROMELANIN | 23 | 86% | 1% | 12 |
7 | DEPENDENT IRON TOXICITY | 23 | 100% | 1% | 10 |
8 | 6 HYDROXYDOPAMINE | 19 | 13% | 8% | 134 |
9 | AMINOCHROME | 17 | 79% | 1% | 11 |
10 | RAT MIDBRAIN NEURONS | 15 | 67% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Oxidative stress in Parkinson's disease | 2003 | 630 | 144 | 49% |
Iron, brain ageing and neurodegenerative disorders | 2004 | 680 | 121 | 29% |
The relevance of iron in the pathogenesis of Parkinson's disease | 2011 | 75 | 140 | 39% |
Protective and toxic roles of dopamine in Parkinson's disease | 2014 | 9 | 153 | 55% |
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease | 2001 | 578 | 443 | 27% |
Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease | 2003 | 215 | 99 | 66% |
Cytotoxic and genotoxic potential of dopamine | 1999 | 272 | 57 | 81% |
Etiology and pathogenesis of Parkinson's disease | 1999 | 812 | 103 | 29% |
Levodopa: Effect on Cell Death and the Natural History of Parkinson's Disease | 2015 | 1 | 51 | 39% |
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators | 2013 | 40 | 204 | 27% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BRUCE R P ORT FAMILY | 13 | 80% | 0.5% | 8 |
2 | SHANDONG PROV PATHOGENESIS PREVENT NEUR | 10 | 40% | 1.1% | 19 |
3 | STATE KEY DISCIPLINES PHYSIOL | 7 | 39% | 0.8% | 14 |
4 | BIOMED CNS | 6 | 100% | 0.2% | 4 |
5 | NEUROANAT NEUROL EXPT | 4 | 75% | 0.2% | 3 |
6 | NEUROBIOL DEV BIOL | 3 | 22% | 0.6% | 11 |
7 | STATE KEY DISCIPLINES PHYSIOL INCUBAT | 3 | 50% | 0.2% | 4 |
8 | CHILD ADOLESCENCE PSYCHIAT PSYCHOTHER Y | 3 | 60% | 0.2% | 3 |
9 | CHILD YOUTH PSYCHIAT PSYCHOTHER Y | 3 | 42% | 0.3% | 5 |
10 | CLIN NEUROCHEM PARKINSON FDN | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000153510 | MPTP//MPP//1 METHYL 4 PHENYL 1 2 3 6 TETRAHYDROPYRIDINE |
2 | 0.0000143484 | BIOMOL INTERACT BREMEN//BIOL CHEM 2//YANGCHUN KU |
3 | 0.0000134156 | ROTENONE//3 4 DIHYDROXYPHENYLGLYCOLALDEHYDE//3 4 DIHYDROXYPHENYLACETALDEHYDE |
4 | 0.0000122475 | NEUROPHARMACOL SECT//NEUROANAT EXPT NEUROL//PHARMACOL CHEM |
5 | 0.0000109815 | GEORGE M LEADER FAMILY ALZHEIMERS DIS//CONDENSED MAT NANOSCI//FERRITIN RECEPTORS |
6 | 0.0000092404 | SALSOLINOL//NORSALSOLINOL//1 METHYL 1 2 3 4 TETRAHYDROISOQUINOLINE |
7 | 0.0000088192 | EUMELANIN//PHEOMELANIN//MELANIN |
8 | 0.0000087956 | L DOPA PRODRUGS//6 HYDROXYDOPAMINE 6 OHDA LESIONED RAT//PROXIMAGEN NEUROSCI PLC |
9 | 0.0000087006 | RASAGILINE//SELEGILINE//DEPRENYL |
10 | 0.0000076635 | SUSCEPTIBILITY WEIGHTED IMAGING//QUANTITATIVE SUSCEPTIBILITY MAPPING//BRAIN IRON |